FDA discloses why drugs don’t make it to market. A pharma company says it’s bad for business

1 hour ago 1

Last year, the FDA started telling the public why it rejects new drugs. Now a pharmaceutical company says that transparency is bad for business — and wants the agency to reconsider.

Last year, the FDA started publicly disclosing why drugs don’t make it to market.

Read Entire Article